Advertisement
Screener

BRISTOL-MYERS SQUIBB COMPANY (BMY) Lessee, Operating Lease, Liability, Undiscounted Excess Amount

2.2 / 5 stars · 48/110 Roast Me

BRISTOL-MYERS SQUIBB COMPANY Lessee, Operating Lease, Liability, Undiscounted Excess Amount

BRISTOL-MYERS SQUIBB COMPANY (BMY) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $542.00 million as of 2025-12-31, per its 10-K filed 2026-02-11.

Financial Statements › Notes › Leases

us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-02-11

  • 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $542.00M.
  • 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $370.00M.
  • 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $438.00M.
  • 2022-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $377.00M.
Period endLessee, Operating Lease, Liability, Undiscounted Excess Amount
2025-12-31$542.00M
10-K · filed 2026-02-11
2024-12-31$370.00M
10-K · filed 2025-02-12
2023-12-31$438.00M
10-K · filed 2024-02-13
2022-12-31$377.00M
10-K · filed 2023-02-14
2021-12-31$148.00M
10-K · filed 2022-02-09
2020-12-31$167.00M
10-K · filed 2021-02-10
2019-12-31$161.00M
10-K · filed 2020-02-24
2019-09-30$145.00M
10-Q · filed 2019-10-31
2019-06-30$149.00M
10-Q · filed 2019-07-25
2019-03-31$155.00M
10-Q · filed 2019-04-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
PFIZER INC (PFE)United States$162.042B31.94
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64